Rey A - Search Results

1

Prognostic factors in non-seminomatous germ cell tumours of the testis. Experience at the Institut Gustave-Roussy.

Kramar A, Droz JP, Rey A, Bouzy J, Philippot I, Culine S. Kramar A, et al. Among authors: rey a. Eur Urol. 1993;23(1):188-95. doi: 10.1159/000474592. Eur Urol. 1993. PMID: 8386648 Review.

2

Prognostic factors in advanced nonseminomatous testicular cancer. A multivariate logistic regression analysis.

Droz JP, Kramar A, Ghosn M, Piot G, Rey A, Theodore C, Wibault P, Court BH, Perrin JL, Travagli JP, et al. Droz JP, et al. Among authors: rey a. Cancer. 1988 Aug 1;62(3):564-8. doi: 10.1002/1097-0142(19880801)62:3<564::aid-cncr2820620321>3.0.co;2-a. Cancer. 1988. PMID: 2455591

3

Prognostic factors for survival in patients with brain metastases from renal cell carcinoma.

Culine S, Bekradda M, Kramar A, Rey A, Escudier B, Droz JP. Culine S, et al. Among authors: rey a. Cancer. 1998 Dec 15;83(12):2548-53. Cancer. 1998. PMID: 9874462

4

Prognostic factors in metastatic disease.

Droz JP, Kramar A, Rey A. Droz JP, et al. Among authors: rey a. Semin Oncol. 1992 Apr;19(2):181-9. Semin Oncol. 1992. PMID: 1372760 No abstract available.

5

A phase II trial of early intensive chemotherapy with autologous bone marrow transplantation in the treatment of poor prognosis non seminomatous germ cell tumors.

Droz JP, Pico JL, Ghosn M, Kramar A, Rey A, Ostronoff M, Baume D. Droz JP, et al. Among authors: rey a. Bull Cancer. 1992;79(5):497-507. Bull Cancer. 1992. PMID: 1421710 Clinical Trial.

6

Prognostic factors of adult metastatic renal carcinoma: a multivariate analysis.

de Forges A, Rey A, Klink M, Ghosn M, Kramar A, Droz JP. de Forges A, et al. Among authors: rey a. Semin Surg Oncol. 1988;4(3):149-54. doi: 10.1002/ssu.2980040302. Semin Surg Oncol. 1988. PMID: 3187293

7

Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia.

Even C, Pautier P, Duvillard P, Floquet A, Kerbrat P, Troalen F, Rey A, Balleyguier C, Tazi Y, Leary A, Augereau P, Morice P, Droz JP, Fizazi K, Lhommé C. Even C, et al. Among authors: rey a. Eur J Cancer. 2014 Aug;50(12):2082-9. doi: 10.1016/j.ejca.2014.05.002. Epub 2014 Jun 5. Eur J Cancer. 2014. PMID: 24910417

8

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladder. The French Federation of Cancer Centers experience.

Boutan-Laroze A, Mahjoubi M, Droz JP, Charrot P, Fargeot P, Kerbrat P, Caty A, Voisin PM, Spielmann M, Rey A, et al. Boutan-Laroze A, et al. Among authors: rey a. Eur J Cancer. 1991;27(12):1690-4. doi: 10.1016/0277-5379(91)90447-l. Eur J Cancer. 1991. PMID: 1782084

9

Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor.

de La Motte Rouge T, Pautier P, Duvillard P, Rey A, Morice P, Haie-Meder C, Kerbrat P, Culine S, Troalen F, Lhommé C. de La Motte Rouge T, et al. Among authors: rey a. Ann Oncol. 2008 Aug;19(8):1435-1441. doi: 10.1093/annonc/mdn162. Epub 2008 Apr 11. Ann Oncol. 2008. PMID: 18408223 Free article.

10

[Negative second-look laparatomy in ovarian cancers. Survival analysis and prognostic factors from 64 cases treated at the Gustave Roussy Institute].

Pautier P, Rey A, Michel G, Castaigne D, Rochard F, Duvillard P, Haie-Meder C, Curcio P, Benedetti-Richard L, Lhommé C. Pautier P, et al. Among authors: rey a. Bull Cancer. 1997 Feb;84(2):147-54. Bull Cancer. 1997. PMID: 9180837 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,254 results

Search Page

Filters